BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16540549)

  • 1. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.
    Finckh A; Choi HK; Wolfe F
    Ann Rheum Dis; 2006 Sep; 65(9):1192-7. PubMed ID: 16540549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.
    Sanmartí R; Gómez-Centeno A; Ercilla G; Larrosa M; Viñas O; Vazquez I; Gómez-Puerta JA; Gratacós J; Salvador G; Cañete JD
    Clin Rheumatol; 2007 Jul; 26(7):1111-8. PubMed ID: 17109060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.
    Mueller RB; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Rheumatology (Oxford); 2014 Apr; 53(4):671-7. PubMed ID: 24352338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis).
    Lukas C; Combe B; Ravaud P; Sibilia J; Landew R; van der Heijde D
    Arthritis Rheum; 2011 Jul; 63(7):1804-11. PubMed ID: 21452295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.
    Kyburz D; Gabay C; Michel BA; Finckh A;
    Rheumatology (Oxford); 2011 Jun; 50(6):1106-10. PubMed ID: 21258051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.
    Sokka T; Kautiainen H; Häkkinen A; Hannonen P
    J Rheumatol; 2004 Jun; 31(6):1073-82. PubMed ID: 15170917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?
    Jawaheer D; Maranian P; Park G; Lahiff M; Amjadi SS; Paulus HE
    J Rheumatol; 2010 Dec; 37(12):2475-85. PubMed ID: 20889597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
    Graudal N
    Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.
    Mueller RB; Schiff M; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Clin Rheumatol; 2015 Jan; 34(1):51-9. PubMed ID: 25024096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
    Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
    J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Radiographic Outcomes in Patients Diagnosed with Early Rheumatoid Arthritis in the First Years of the Biologic Treatment Era: A 10-year Prospective Observational Study.
    Haugeberg G; Bøyesen P; Helgetveit K; Prøven A
    J Rheumatol; 2015 Dec; 42(12):2279-87. PubMed ID: 26568592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
    Graudal N; Jürgens G
    Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
    Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.
    Weng HH; Ranganath VK; Khanna D; Oh M; Furst DE; Park GS; Elashoff DA; Sharp JT; Gold RH; Peter JB; Paulus HE;
    J Rheumatol; 2010 Mar; 37(3):550-7. PubMed ID: 20110517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.